GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » Net Margin %

Univo Pharmaceuticals (XTAE:UNVO-M) Net Margin % : -198.84% (As of Jun. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Univo Pharmaceuticals's Net Income for the three months ended in Jun. 2022 was ₪-21.00 Mil. Univo Pharmaceuticals's Revenue for the three months ended in Jun. 2022 was ₪10.56 Mil. Therefore, Univo Pharmaceuticals's net margin for the quarter that ended in Jun. 2022 was -198.84%.

The historical rank and industry rank for Univo Pharmaceuticals's Net Margin % or its related term are showing as below:


XTAE:UNVO-M's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -109.01
* Ranked among companies with meaningful Net Margin % only.

Univo Pharmaceuticals Net Margin % Historical Data

The historical data trend for Univo Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals Net Margin % Chart

Univo Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Net Margin %
Get a 7-Day Free Trial Premium Member Only - - -1,430.70 0.54 -14.83

Univo Pharmaceuticals Quarterly Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.24 -32.07 -25.86 -45.53 -198.84

Competitive Comparison of Univo Pharmaceuticals's Net Margin %

For the Biotechnology subindustry, Univo Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Univo Pharmaceuticals's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Univo Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Univo Pharmaceuticals's Net Margin % falls into.


;
;

Univo Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Univo Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Net Margin=Net Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-6.263/42.227
=-14.83 %

Univo Pharmaceuticals's Net Margin for the quarter that ended in Jun. 2022 is calculated as

Net Margin=Net Income (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-21.002/10.562
=-198.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Univo Pharmaceuticals  (XTAE:UNVO-M) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Univo Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Univo Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Harshar 20, Ashkelon, ISR, 7878329
Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines